
Sign up to save your podcasts
Or


Alcoa kicks off earnings season, but it’s biotech Illumina that in the spotlight (and not for good reasons). Bill Barker and Bill Mann from Motley Fool Funds discuss those stories plus Samsung’s decision to kill the Galaxy Note 7, Warren Buffett’s response to Donald Trump, a couple of tangents and more.
By The Motley Fool4.7
16041,604 ratings
Alcoa kicks off earnings season, but it’s biotech Illumina that in the spotlight (and not for good reasons). Bill Barker and Bill Mann from Motley Fool Funds discuss those stories plus Samsung’s decision to kill the Galaxy Note 7, Warren Buffett’s response to Donald Trump, a couple of tangents and more.

3,221 Listeners

1,488 Listeners

807 Listeners

948 Listeners

523 Listeners

1,166 Listeners

2,182 Listeners

825 Listeners

1,422 Listeners

1,037 Listeners

9,717 Listeners

196 Listeners

826 Listeners

87 Listeners

585 Listeners

1,036 Listeners

53 Listeners